TY - JOUR KW - Adaptive Immunity KW - Antigens, Bacterial KW - Complement Activation KW - Complement C3 KW - Dendritic Cells KW - Glycolipids KW - Humans KW - Interleukin-10 KW - leprosy KW - Mycobacterium leprae KW - T-Lymphocytes AU - Callegaro-Filho D AU - Shrestha N AU - Burdick A AU - Haslett P AB -

Lepromatous leprosy is a model of immune evasion wherein pathogen-specific IL-10-secreting T cells and concomitant failure of Th-1 immunity permit uncontrolled proliferation of the intracellular pathogen, Mycobacterium leprae (M. leprae). The mechanism of this immune escape is unknown. Here, the authors report that phenolic glycolipid-1 (PGL-1), a major and distinguishing feature of the M. leprae cell wall, is expressed in the cell membrane of M. leprae-infected human dendritic cells, where it can activate complement in human serum. The authors demonstrate that PGL-1 and the C3 component of complement colocalize in lipid rafts in the dendritic cell membrane, and enter the immune synapse upon co-culture of M. leprae-infected DCs and T cells. Hence, activated C3 is strategically located to costimulate naïve T cells via the complement regulatory protein, CD46, a process known to stimulate the differentiation of IL-10-secreting regulatory T cells. These observations suggest a potential novel mechanism of immune evasion, wherein M. leprae may subvert host natural immunity to provoke an adaptive response that favors bacillary survival.

BT - Journal of drugs in dermatology : JDD C1 - http://www.ncbi.nlm.nih.gov/pubmed/21061760?dopt=Abstract DA - 2010 Nov DO - 10.2340/16501977-0625 IS - 11 J2 - J Drugs Dermatol LA - eng N2 -

Lepromatous leprosy is a model of immune evasion wherein pathogen-specific IL-10-secreting T cells and concomitant failure of Th-1 immunity permit uncontrolled proliferation of the intracellular pathogen, Mycobacterium leprae (M. leprae). The mechanism of this immune escape is unknown. Here, the authors report that phenolic glycolipid-1 (PGL-1), a major and distinguishing feature of the M. leprae cell wall, is expressed in the cell membrane of M. leprae-infected human dendritic cells, where it can activate complement in human serum. The authors demonstrate that PGL-1 and the C3 component of complement colocalize in lipid rafts in the dendritic cell membrane, and enter the immune synapse upon co-culture of M. leprae-infected DCs and T cells. Hence, activated C3 is strategically located to costimulate naïve T cells via the complement regulatory protein, CD46, a process known to stimulate the differentiation of IL-10-secreting regulatory T cells. These observations suggest a potential novel mechanism of immune evasion, wherein M. leprae may subvert host natural immunity to provoke an adaptive response that favors bacillary survival.

PY - 2010 SP - 1373 EP - 82 T2 - Journal of drugs in dermatology : JDD TI - A potential role for complement in immune evasion by Mycobacterium leprae. VL - 9 SN - 1545-9616 ER -